A. Isaacs and J. Lindenmann, Virus Interference. I. The Interferon, Proceedings of the Royal Society B: Biological Sciences, vol.147, issue.927, pp.258-67, 1957.
DOI : 10.1098/rspb.1957.0048

A. Isaacs, J. Lindenmann, and R. Valentine, Virus Interference. II. Some Properties of Interferon, Proceedings of the Royal Society B: Biological Sciences, vol.147, issue.927, pp.268-73, 1957.
DOI : 10.1098/rspb.1957.0049

U. Muller, U. Steinhoff, L. Reis, S. Hemmi, J. Pavlovic et al., Functional role of type I and type II interferons in antiviral defense, Science, vol.264, issue.5167, pp.1918-1939, 1994.
DOI : 10.1126/science.8009221

S. Zhang, S. Boisson-dupuis, A. Chapgier, K. Yang, J. Bustamante et al., Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-??/??, IFN-??, and IFN-?? in host defense, Immunological Reviews, vol.226, issue.1, pp.29-40, 2008.
DOI : 10.1111/j.1600-065X.2008.00698.x

J. Fenner, R. Starr, A. Cornish, J. Zhang, D. Metcalf et al., Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity, Nature Immunology, vol.162, issue.1, pp.33-910, 1038.
DOI : 10.1038/ni1287

D. Mittal, M. Gubin, R. Schreiber, and M. Smyth, New insights into cancer immunoediting and its three component phases???elimination, equilibrium and escape, Current Opinion in Immunology, vol.27, pp.16-25, 2014.
DOI : 10.1016/j.coi.2014.01.004

A. Reder and X. Feng, How Type I Interferons Work in Multiple Sclerosis and Other Diseases: Some Unexpected Mechanisms, Journal of Interferon & Cytokine Research, vol.34, issue.8, pp.589-99, 2014.
DOI : 10.1089/jir.2013.0158

R. Malireddi and T. Kanneganti, Role of type I interferons in inflammasome activation, cell death, and disease during microbial infection, Frontiers in Cellular and Infection Microbiology, vol.3, 2013.
DOI : 10.3389/fcimb.2013.00077

Y. Furuya, D. Steiner, and D. Metzger, Does Type I interferon limit protective neutrophil responses during pulmonary Francisella Tularensis infection? Front Immunol, 2014.

L. Lenz and E. Eshleman, Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity, Front Immunol, 2014.

D. Domizio, J. Cao, and W. , Fueling autoimmunity: type I interferon in autoimmune diseases, Expert Review of Clinical Immunology, vol.9, issue.3, 2013.
DOI : 10.1586/eci.12.106

J. Herbeuval and G. Shearer, HIV-1 immunopathogenesis: How good interferon turns bad, Clinical Immunology, vol.123, issue.2, pp.121-129, 2007.
DOI : 10.1016/j.clim.2006.09.016
URL : https://hal.archives-ouvertes.fr/hal-00110852

J. Teijaro, C. Ng, A. Lee, B. Sullivan, K. Sheehan et al., Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling, Science, vol.340, issue.6129, pp.207-218, 2013.
DOI : 10.1126/science.1235214

E. Wilson, D. Yamada, H. Elsaesser, J. Herskovitz, J. Deng et al., Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection, Science, vol.340, issue.6129, pp.202-209, 2013.
DOI : 10.1126/science.1235208

D. Wijesundara, Y. Xi, and C. Ranasinghe, Unraveling the Convoluted Biological Roles of Type I Interferons in Infection and Immunity: A Way Forward for Therapeutics and Vaccine Design, Frontiers in Immunology, vol.280, issue.5362, 2014.
DOI : 10.1126/science.280.5362.427

S. Pestka, C. Krause, and M. Walter, Interferons, interferon-like cytokines, and their receptors, Immunological Reviews, vol.11, issue.1, pp.8-32, 2004.
DOI : 10.1107/S0907444999014304

M. Dalod, R. Chelbi, B. Malissen, and T. Lawrence, Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming, The EMBO Journal, vol.33, issue.10, pp.1104-1120, 2014.
DOI : 10.1002/embj.201488027

G. Garcin, F. Paul, M. Staufenbiel, Y. Bordat, J. Van-der-heyden et al., High efficiency cell-specific targeting of cytokine activity, Nature Communications, vol.1, 2014.
DOI : 10.1038/ncomms4016

A. Hsu, K. Parsons, I. Barr, S. Lowther, D. Middleton et al., Critical Role of Constitutive Type I Interferon Response in Bronchial Epithelial Cell to Influenza Infection, PLoS ONE, vol.286, issue.3, 2012.
DOI : 10.1371/journal.pone.0032947.s003

Y. Tsugawa, H. Kato, T. Fujita, K. Shimotohno, and M. Hijikata, Critical role of interferon-alpha constitutively produced in human hepatocytes in response to RNA virus infection, PLoS One, vol.9, issue.2, 2014.

J. Jablonska, S. Leschner, K. Westphal, S. Lienenklaus, and S. Weiss, Neutrophils responsive to endogenous IFN-?? regulate tumor angiogenesis and growth in a mouse tumor model, Journal of Clinical Investigation, vol.120, issue.4, pp.1151-64, 2010.
DOI : 10.1172/JCI37223DS1

H. Chen, N. Tanaka, Y. Mitani, E. Oda, H. Nozawa et al., Critical role for constitutive type I interferon signaling in the prevention of cellular transformation, Cancer Science, vol.6, issue.3, pp.449-56, 2009.
DOI : 10.1111/j.1349-7006.2008.01051.x

S. Kim, V. Kaiser, E. Beier, M. Bechheim, M. Guenthner-biller et al., Self-priming determines high type I IFN production by plasmacytoid dendritic cells, European Journal of Immunology, vol.182, issue.3, pp.807-825, 2014.
DOI : 10.1002/eji.201343806

D. Otero, D. Baker, and M. David, IRF7-Dependent IFN-?? Production in Response to RANKL Promotes Medullary Thymic Epithelial Cell Development, The Journal of Immunology, vol.190, issue.7, pp.3289-98, 2013.
DOI : 10.4049/jimmunol.1203086

H. Li, A. Gelbard, G. Martinez, E. Esashi, H. Zhang et al., Cell-intrinsic role for IFN-??-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response, Blood, vol.118, issue.14, pp.3879-89, 2011.
DOI : 10.1182/blood-2011-04-349761

N. Zietara, M. Lyszkiewicz, N. Gekara, J. Puchalka, D. Santos et al., Absence of IFN-beta impairs antigen presentation capacity of splenic dendritic cells via down-regulation of heat shock protein 70, J Immunol, vol.183, issue.2, pp.1099-109, 2009.

T. Taniguchi and A. Takaoka, A weak signal for strong responses: interferon-alpha/beta revisited, Nature Reviews Molecular Cell Biology, vol.65, issue.5, pp.378-86, 2001.
DOI : 10.1038/35073080

S. Lienenklaus, M. Cornitescu, N. Zietara, M. Lyszkiewicz, N. Gekara et al., Novel Reporter Mouse Reveals Constitutive and Inflammatory Expression of IFN-?? In Vivo, The Journal of Immunology, vol.183, issue.5, pp.3229-3265, 2009.
DOI : 10.4049/jimmunol.0804277

J. Pulverer, R. U. Lienenklaus, S. Kugel, D. Zietara, N. Kochs et al., Temporal and Spatial Resolution of Type I and III Interferon Responses In Vivo, Journal of Virology, vol.84, issue.17, pp.8626-3800303, 2010.
DOI : 10.1128/JVI.00303-10

S. Ganal, S. Sanos, C. Kallfass, K. Oberle, C. Johner et al., Priming of Natural Killer Cells by Nonmucosal Mononuclear Phagocytes Requires Instructive Signals from Commensal Microbiota, Immunity, vol.37, issue.1, pp.171-86, 2012.
DOI : 10.1016/j.immuni.2012.05.020

S. Paludan and A. Bowie, Immune Sensing of DNA, Immunity, vol.38, issue.5, pp.870-80, 2013.
DOI : 10.1016/j.immuni.2013.05.004

D. Goubau, S. Deddouche, R. Sousa, and C. , Cytosolic Sensing of Viruses, Immunity, vol.38, issue.5, pp.855-69, 2013.
DOI : 10.1016/j.immuni.2013.05.007

I. Marie, J. Durbin, and D. Levy, Differential viral induction of distinct interferonalpha genes by positive feedback through interferon regulatory factor-7, EMBO J, vol.1722, issue.22, pp.6660-6669, 1998.

M. Sato, N. Hata, M. Asagiri, T. Nakaya, T. Taniguchi et al., Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7, FEBS Lett, vol.4411, issue.98, pp.106-116, 1998.

C. Holm, S. Jensen, M. Jakobsen, N. Cheshenko, K. Horan et al., Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING, Nature Immunology, vol.72, issue.8, pp.737-780, 2012.
DOI : 10.1016/j.immuni.2011.05.016

D. Hare and K. Mossman, Novel paradigms of innate immune sensing of viral infections, Cytokine, vol.63, issue.3, pp.219-243, 2013.
DOI : 10.1016/j.cyto.2013.06.001

D. Olagnier and J. Hiscott, Breaking the barrier: membrane fusion triggers innate antiviral immunity, Nature Immunology, vol.13, issue.8, pp.713-718, 2012.
DOI : 10.1038/cr.2010.178

D. Goubau, M. Schlee, S. Deddouche, A. Pruijssers, T. Zillinger et al., Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5???-diphosphates, Nature, vol.498, issue.7522, p.10, 1038.
DOI : 10.1038/nature13590

C. Bonjardim, P. Ferreira, and E. Kroon, Interferons: Signaling, antiviral and viral evasion, Immunology Letters, vol.122, issue.1, pp.1-11, 2009.
DOI : 10.1016/j.imlet.2008.11.002

S. Furr, V. Chauhan, M. Moerdyk-schauwecker, and I. Marriott, A role for DNA-dependent activator of interferon regulatory factor in the recognition of herpes simplex virus type 1 by glial cells, Journal of Neuroinflammation, vol.8, issue.1, pp.99-109, 2011.
DOI : 10.1128/JVI.01106-10

L. Sun, J. Wu, F. Du, X. Chen, and Z. Chen, Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway, Science, vol.339, issue.6121, pp.786-91, 2013.
DOI : 10.1126/science.1232458

X. Lahaye, T. Satoh, M. Gentili, S. Cerboni, C. Conrad et al., The Capsids of HIV-1 and HIV-2 Determine Immune Detection of the Viral cDNA by the Innate Sensor cGAS in Dendritic Cells, Immunity, vol.39, issue.6, pp.1132-1174, 2013.
DOI : 10.1016/j.immuni.2013.11.002
URL : https://hal.archives-ouvertes.fr/inserm-00959028

J. Schoggins, D. Macduff, N. Imanaka, M. Gainey, B. Shrestha et al., Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity, Nature, vol.3, issue.7485, pp.691-510, 1038.
DOI : 10.1038/nature12862

N. Claudio, A. Dalet, E. Gatti, and P. Pierre, Mapping the crossroads of immune activation and cellular stress response pathways, The EMBO Journal, vol.70, issue.9, pp.1214-1238, 2013.
DOI : 10.1038/nature07203

M. Severa and K. Fitzgerald, TLR-Mediated Activation of Type I IFN During Antiviral Immune Responses: Fighting the Battle to Win the War, Curr Top Microbiol Immunol, vol.316, pp.167-92, 2007.
DOI : 10.1007/978-3-540-71329-6_9

T. Baranek, N. Zucchini, and M. Dalod, Plasmacytoid Dendritic Cells and the Control of Herpesvirus Infections, Viruses, vol.1, issue.3, pp.383-41910, 2009.
DOI : 10.3390/v1030383

T. Ito, H. Kanzler, O. Duramad, W. Cao, and Y. Liu, Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells, Blood, vol.107, issue.6, pp.2423-2454, 2006.
DOI : 10.1182/blood-2005-07-2709

M. Cella, D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima et al., Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon, Nat Med, vol.5, issue.8, pp.919-2310, 1038.

F. Siegal, N. Kadowaki, M. Shodell, P. Fitzgerald-bocarsly, K. Shah et al., The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood, Science, vol.284, issue.5421, pp.1835-1842, 1999.
DOI : 10.1126/science.284.5421.1835

C. Asselin-paturel, A. Boonstra, M. Dalod, I. Durand, N. Yessaad et al., Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology, Nature Immunology, vol.250, issue.12, pp.1144-5010, 1038.
DOI : 10.1006/clim.2000.4858

W. Barchet, M. Cella, B. Odermatt, C. Asselin-paturel, M. Colonna et al., Virus-induced Interferon ?? Production by a Dendritic Cell Subset in the Absence of Feedback Signaling In Vivo, The Journal of Experimental Medicine, vol.43, issue.4, pp.507-523, 2002.
DOI : 10.1182/blood.V98.4.906

A. Krug, A. French, W. Barchet, J. Fischer, A. Dzionek et al., TLR9-Dependent Recognition of MCMV by IPC and DC Generates Coordinated Cytokine Responses that Activate Antiviral NK Cell Function, Immunity, vol.21, issue.1, pp.107-126, 2004.
DOI : 10.1016/j.immuni.2004.06.007

S. Diebold, M. Montoya, H. Unger, L. Alexopoulou, P. Roy et al., Viral infection switches non-plasmacytoid dendritic cells into high interferon producers, Nature, vol.424, issue.6946, pp.324-332, 1783.
DOI : 10.1038/nature01783

M. Swiecki, S. Gilfillan, W. Vermi, Y. Wang, and M. Colonna, Plasmacytoid Dendritic Cell Ablation Impacts Early Interferon Responses and Antiviral NK and CD8+ T Cell Accrual, Immunity, vol.33, issue.6, pp.955-66, 2010.
DOI : 10.1016/j.immuni.2010.11.020

L. Cervantes-barragan, R. Zust, F. Weber, M. Spiegel, K. Lang et al., Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon, Blood, vol.109, issue.3, pp.1131-1138, 2007.
DOI : 10.1182/blood-2006-05-023770

M. Swiecki, Y. Wang, S. Gilfillan, and M. Colonna, Plasmacytoid Dendritic Cells Contribute to Systemic but Not Local Antiviral Responses to HSV Infections, PLoS Pathogens, vol.294, issue.10, 2013.
DOI : 10.1371/journal.ppat.1003728.g006

M. Dalod, T. Hamilton, R. Salomon, T. Salazar-mather, S. Henry et al., Dendritic Cell Responses to Early Murine Cytomegalovirus Infection, The Journal of Experimental Medicine, vol.161, issue.7, pp.885-98, 2003.
DOI : 10.1084/jem.189.8.1315

M. Dalod, T. Salazar-mather, L. Malmgaard, C. Lewis, C. Asselin-paturel et al., Interferon ??/?? and Interleukin 12 Responses to Viral Infections, The Journal of Experimental Medicine, vol.162, issue.4, pp.517-545, 2002.
DOI : 10.1093/intimm/13.4.465

N. Zucchini, G. Bessou, S. Robbins, L. Chasson, A. Raper et al., Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection, International Immunology, vol.20, issue.1, pp.45-56, 2008.
DOI : 10.1093/intimm/dxm119
URL : https://hal.archives-ouvertes.fr/hal-00294212

O. Takeuchi and S. Akira, Pattern Recognition Receptors and Inflammation, Cell, vol.140, issue.6, pp.805-825, 2010.
DOI : 10.1016/j.cell.2010.01.022

A. Blasius and B. Beutler, Intracellular Toll-like Receptors, Immunity, vol.32, issue.3, pp.305-320, 2010.
DOI : 10.1016/j.immuni.2010.03.012

Y. Alexandre, C. Cocita, S. Ghilas, and M. Dalod, Deciphering the role of DC subsets in MCMV infection to better understand immune protection against viral infections, Frontiers in Microbiology, vol.180, issue.10, 2014.
DOI : 10.4049/jimmunol.180.9.5799

M. Merad, P. Sathe, J. Helft, J. Miller, and A. Mortha, The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting, Annual Review of Immunology, vol.31, issue.1, pp.563-604, 2013.
DOI : 10.1146/annurev-immunol-020711-074950

H. Lauterbach, B. Bathke, S. Gilles, C. Traidl-hoffmann, C. Luber et al., DCs are major producers of IFN-?? in response to poly IC, The Journal of Experimental Medicine, vol.95, issue.12, pp.2703-2720, 2010.
DOI : 10.1126/science.1109893

S. Balan, V. Ollion, N. Colletti, R. Chelbi, F. Montanana-sanchis et al., Progenitors Closely Resemble Blood Dendritic Cells, Including Their Adjuvant Responsiveness, Contrary to Monocyte-Derived Dendritic Cells, The Journal of Immunology, vol.193, issue.4, pp.1622-1657, 2014.
DOI : 10.4049/jimmunol.1401243

S. Zhang, K. Kodys, K. Li, and G. Szabo, Human Type 2 Myeloid Dendritic Cells Produce Interferon-?? and Amplify Interferon-?? in Response to Hepatitis C Virus Infection, Gastroenterology, vol.144, issue.2, pp.414-425, 2013.
DOI : 10.1053/j.gastro.2012.10.034

S. Yoshio, T. Kanto, S. Kuroda, T. Matsubara, K. Higashitani et al., dendritic cells are a potent producer of interferon-?? in response to hepatitis C virus, Hepatology, vol.86, issue.5, pp.1705-1720, 2013.
DOI : 10.1002/hep.26182

J. Zhu, Y. Zhang, A. Ghosh, R. Cuevas, A. Forero et al., Antiviral Activity of Human OASL Protein Is Mediated by Enhancing Signaling of the RIG-I RNA Sensor, Immunity, vol.40, issue.6, pp.936-984, 2014.
DOI : 10.1016/j.immuni.2014.05.007

P. Luthra, D. Sun, R. Silverman, and B. He, Activation of IFN-?? expression by a viral mRNA through RNase L and MDA5, Proceedings of the National Academy of Sciences, vol.108, issue.5, pp.2118-2141, 2011.
DOI : 10.1073/pnas.1012409108

K. Malathi, T. Saito, N. Crochet, D. Barton, M. Gale et al., RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP, RNA, vol.16, issue.11, pp.2108-2127, 2010.
DOI : 10.1261/rna.2244210

O. Schulz, A. Pichlmair, J. Rehwinkel, N. Rogers, D. Scheuner et al., Protein Kinase R Contributes to Immunity against Specific Viruses by Regulating Interferon mRNA Integrity, Cell Host & Microbe, vol.7, issue.5, pp.354-61, 2010.
DOI : 10.1016/j.chom.2010.04.007

C. Rothlin, S. Ghosh, E. Zuniga, M. Oldstone, and G. Lemke, TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response, Cell, vol.131, issue.6, pp.1124-1160, 2007.
DOI : 10.1016/j.cell.2007.10.034

Y. Kumagai, O. Takeuchi, H. Kato, H. Kumar, K. Matsui et al., Alveolar Macrophages Are the Primary Interferon-?? Producer in Pulmonary Infection with RNA Viruses, Immunity, vol.27, issue.2, pp.240-52, 2007.
DOI : 10.1016/j.immuni.2007.07.013

N. Jewell, N. Vaghefi, S. Mertz, P. Akter, R. Peebles et al., Differential Type I Interferon Induction by Respiratory Syncytial Virus and Influenza A Virus In Vivo, Journal of Virology, vol.81, issue.18, pp.9790-80000530, 2007.
DOI : 10.1128/JVI.00530-07

K. Crozat, E. Vivier, and M. Dalod, Crosstalk between components of the innate immune system: promoting anti-microbial defenses and avoiding immunopathologies, Immunological Reviews, vol.455, issue.1, pp.129-178, 2009.
DOI : 10.1111/j.1600-065X.2008.00736.x
URL : https://hal.archives-ouvertes.fr/hal-00403241

M. Kaminski, A. Ohnemus, M. Cornitescu, and P. Staeheli, Plasmacytoid dendritic cells and Toll-like receptor 7-dependent signalling promote efficient protection of mice against highly virulent influenza A virus, Journal of General Virology, vol.93, issue.3, pp.555-564, 2012.
DOI : 10.1099/vir.0.039065-0

A. Wolf, D. Buehler, S. Hensley, L. Cavanagh, E. Wherry et al., Plasmacytoid Dendritic Cells Are Dispensable during Primary Influenza Virus Infection, The Journal of Immunology, vol.182, issue.2, pp.871-880, 2009.
DOI : 10.4049/jimmunol.182.2.871

C. Geurtsvankessel, M. Willart, L. Van-rijt, F. Muskens, M. Kool et al., but not plasmacytoid dendritic cells, The Journal of Experimental Medicine, vol.73, issue.7, pp.1621-1655, 2008.
DOI : 10.1017/S0022172400069412

K. Yang, A. Puel, S. Zhang, C. Eidenschenk, C. Ku et al., Human TLR-7-, -8-, and -9-Mediated Induction of IFN-??/?? and -?? Is IRAK-4 Dependent and Redundant for Protective Immunity to Viruses, Immunity, vol.23, issue.5, pp.465-78, 2005.
DOI : 10.1016/j.immuni.2005.09.016

H. Von-bernuth, C. Picard, J. Z. Pankla, R. Xiao, H. Ku et al., Pyogenic Bacterial Infections in Humans with MyD88 Deficiency, Science, vol.321, issue.5889, pp.691-697, 2008.
DOI : 10.1126/science.1158298

S. Dupuis, E. Jouanguy, S. Al-hajjar, C. Fieschi, I. Al-mohsen et al., Impaired response to interferon-??/?? and lethal viral disease in human STAT1 deficiency, Nature Genetics, vol.33, issue.3, pp.388-9110, 1038.
DOI : 10.1038/ng1097

Y. Guo, M. Audry, M. Ciancanelli, L. Alsina, J. Azevedo et al., Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity, The Journal of Experimental Medicine, vol.17, issue.10, pp.2083-98, 2011.
DOI : 10.1126/science.1139522

V. Sancho-shimizu, R. Perez-de-diego, L. Lorenzo, R. Halwani, A. Alangari et al., Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency, Journal of Clinical Investigation, vol.121, issue.12, pp.4889-90210, 1172.
DOI : 10.1172/JCI59259DS1

L. Barreiro, M. Ben-ali, H. Quach, G. Laval, E. Patin et al., Evolutionary Dynamics of Human Toll-Like Receptors and Their Different Contributions to Host Defense, PLoS Genetics, vol.296, issue.7, 2009.
DOI : 10.1371/journal.pgen.1000562.s019

A. Garcia-sastre and C. Biron, Type 1 Interferons and the Virus-Host Relationship: A Lesson in Detente, Science, vol.312, issue.5775, pp.879-82, 2006.
DOI : 10.1126/science.1125676

M. Iannacone, E. Moseman, E. Tonti, L. Bosurgi, T. Junt et al., Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus, Nature, vol.105, issue.7301, pp.1079-8310, 1038.
DOI : 10.1038/nature09118

N. Honke, N. Shaabani, G. Cadeddu, U. Sorg, D. Zhang et al., Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus, Nature Immunology, vol.150, issue.1, pp.51-58, 2012.
DOI : 10.1073/pnas.89.1.314

W. Schneider, M. Chevillotte, and C. Rice, Interferon-Stimulated Genes: A Complex Web of Host Defenses, Annual Review of Immunology, vol.32, issue.1, pp.513-558, 2014.
DOI : 10.1146/annurev-immunol-032713-120231

C. Pfaller, Z. Li, C. George, and C. Samuel, Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response, Current Opinion in Immunology, vol.23, issue.5, pp.573-82, 2011.
DOI : 10.1016/j.coi.2011.08.009

R. Harris, K. Bishop, A. Sheehy, H. Craig, S. Petersen-mahrt et al., DNA Deamination Mediates Innate Immunity to Retroviral Infection, Cell, vol.113, issue.6, pp.803-812, 2003.
DOI : 10.1016/S0092-8674(03)00423-9

A. Sze, D. Olagnier, R. Lin, J. Van-grevenynghe, and J. Hiscott, SAMHD1 Host Restriction Factor: A Link with Innate Immune Sensing of Retrovirus Infection, Journal of Molecular Biology, vol.425, issue.24, pp.4981-94, 2013.
DOI : 10.1016/j.jmb.2013.10.022

J. Schoggins, S. Wilson, M. Panis, M. Murphy, C. Jones et al., A diverse range of gene products are effectors of the type I interferon antiviral response, Nature, vol.81, issue.7344, pp.481-486, 2011.
DOI : 10.1038/nature09907

M. Blanc, W. Hsieh, K. Robertson, K. Kropp, T. Forster et al., The Transcription Factor STAT-1 Couples Macrophage Synthesis of 25-Hydroxycholesterol to the Interferon Antiviral Response, Immunity, vol.38, issue.1, pp.106-124, 2013.
DOI : 10.1016/j.immuni.2012.11.004

G. Seo, R. Kincaid, T. Phanaksri, J. Burke, J. Pare et al., Reciprocal Inhibition between Intracellular Antiviral Signaling and the RNAi Machinery in Mammalian Cells, Cell Host & Microbe, vol.14, issue.4, pp.435-480, 2013.
DOI : 10.1016/j.chom.2013.09.002

T. Vu-manh, Y. Alexandre, T. Baranek, K. Crozat, and M. Dalod, Plasmacytoid, conventional, and monocyte-derived dendritic cells undergo a profound and convergent genetic reprogramming during their maturation, European Journal of Immunology, vol.13, issue.7, pp.1706-1721, 2013.
DOI : 10.1002/eji.201243106

L. Bon, A. Etchart, N. Rossmann, C. Ashton, M. Hou et al., Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon, Nature Immunology, vol.4, issue.10, pp.1009-1510, 1038.
DOI : 10.1038/ni978

M. Diamond, M. Kinder, H. Matsushita, M. Mashayekhi, G. Dunn et al., Type I interferon is selectively required by dendritic cells for immune rejection of tumors, The Journal of Experimental Medicine, vol.134, issue.10, pp.1989-2003, 2011.
DOI : 10.4049/jimmunol.0803214

M. Fuertes, A. Kacha, J. Kline, S. Woo, D. Kranz et al., dendritic cells, The Journal of Experimental Medicine, vol.61, issue.10, pp.2005-2021, 2011.
DOI : 10.1158/0008-5472.CAN-07-5324

M. Longhi, C. Trumpfheller, J. Idoyaga, M. Caskey, I. Matos et al., Th1 immunity with poly IC as adjuvant, The Journal of Experimental Medicine, vol.161, issue.7, pp.1589-602, 2009.
DOI : 10.4049/jimmunol.181.10.6923

A. Pantel, A. Teixeira, E. Haddad, E. Wood, R. Steinman et al., Direct Type I IFN but Not MDA5/TLR3 Activation of Dendritic Cells Is Required for Maturation and Metabolic Shift to Glycolysis after Poly IC Stimulation, PLoS Biology, vol.91, issue.1, 2014.
DOI : 10.1371/journal.pbio.1001759.s003

L. Bon, A. Schiavoni, G. , D. Agostino, G. Gresser et al., Type I Interferons Potently Enhance Humoral Immunity and Can Promote Isotype Switching by Stimulating Dendritic Cells In Vivo, Immunity, vol.14, issue.4, pp.461-70, 2001.
DOI : 10.1016/S1074-7613(01)00126-1

H. Cucak, U. Yrlid, B. Reizis, U. Kalinke, and B. Johansson-lindbom, Type I Interferon Signaling in Dendritic Cells Stimulates the Development of Lymph-Node-Resident T Follicular Helper Cells, Immunity, vol.31, issue.3, pp.491-501, 2009.
DOI : 10.1016/j.immuni.2009.07.005

T. Baranek, T. Manh, Y. Alexandre, M. Maqbool, J. Cabeza et al., Differential Responses of Immune Cells to Type I Interferon Contribute to Host Resistance to Viral Infection, Cell Host & Microbe, vol.12, issue.4, pp.571-84, 2012.
DOI : 10.1016/j.chom.2012.09.002

G. Gautier, M. Humbert, F. Deauvieau, M. Scuiller, J. Hiscott et al., A type I interferon autocrine???paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells, The Journal of Experimental Medicine, vol.161, issue.9, pp.1435-1481, 2005.
DOI : 10.1182/blood-2003-02-0500

B. Everts, E. Amiel, S. Huang, A. Smith, C. Chang et al., TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK?? supports the anabolic demands of dendritic cell activation, Nature Immunology, vol.346, issue.4, pp.323-355, 2014.
DOI : 10.1038/nature08097

L. Cervantes-barragan, U. Kalinke, R. Zust, M. Konig, B. Reizis et al., Type I IFN-Mediated Protection of Macrophages and Dendritic Cells Secures Control of Murine Coronavirus Infection, The Journal of Immunology, vol.182, issue.2, pp.1099-106, 2009.
DOI : 10.4049/jimmunol.182.2.1099

J. Martinez, X. Huang, and Y. Yang, Direct Action of Type I IFN on NK Cells Is Required for Their Activation in Response to Vaccinia Viral Infection In Vivo, The Journal of Immunology, vol.180, issue.3, pp.1592-1599, 2008.
DOI : 10.4049/jimmunol.180.3.1592

M. Lucas, W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach, Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15, Immunity, vol.26, issue.4, pp.503-520, 2007.
DOI : 10.1016/j.immuni.2007.03.006

C. Havenar-daughton, G. Kolumam, and K. Murali-krishna, Cutting Edge: The Direct Action of Type I IFN on CD4 T Cells Is Critical for Sustaining Clonal Expansion in Response to a Viral but Not a Bacterial Infection, The Journal of Immunology, vol.176, issue.6, pp.3315-3324, 2006.
DOI : 10.4049/jimmunol.176.6.3315

G. Kolumam, S. Thomas, L. Thompson, J. Sprent, and K. Murali-krishna, Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection, The Journal of Experimental Medicine, vol.4, issue.5, pp.637-50, 2005.
DOI : 10.1038/37648

L. Bon, A. Durand, V. Kamphuis, E. Thompson, C. Bulfone-paus et al., Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming, The Journal of Immunology, vol.176, issue.8, pp.4682-4691, 2006.
DOI : 10.4049/jimmunol.176.8.4682

L. Bon, A. Thompson, C. Kamphuis, E. Durand, V. Rossmann et al., Cutting Edge: Enhancement of Antibody Responses Through Direct Stimulation of B and T Cells by Type I IFN, The Journal of Immunology, vol.176, issue.4, pp.2074-2082, 2006.
DOI : 10.4049/jimmunol.176.4.2074

P. Aichele, H. Unsoeld, M. Koschella, O. Schweier, U. Kalinke et al., Cutting Edge: CD8 T Cells Specific for Lymphocytic Choriomeningitis Virus Require Type I IFN Receptor for Clonal Expansion, The Journal of Immunology, vol.176, issue.8, pp.4525-4534, 2006.
DOI : 10.4049/jimmunol.176.8.4525

L. Thompson, G. Kolumam, S. Thomas, and K. Murali-krishna, Innate Inflammatory Signals Induced by Various Pathogens Differentially Dictate the IFN-I Dependence of CD8 T Cells for Clonal Expansion and Memory Formation, The Journal of Immunology, vol.177, issue.3, pp.1746-54, 2006.
DOI : 10.4049/jimmunol.177.3.1746

T. Frenz, Z. Waibler, J. Hofmann, M. Hamdorf, M. Lantermann et al., Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion, European Journal of Immunology, vol.187, issue.10
DOI : 10.1002/eji.201040453

C. Munz, J. Lunemann, M. Getts, and S. Miller, Antiviral immune responses: triggers of or triggered by autoimmunity?, Nature Reviews Immunology, vol.34, issue.4, pp.246-58, 2009.
DOI : 10.1038/nri2527

L. Fry, B. Baker, A. Powles, A. Fahlen, and L. Engstrand, Is chronic plaque psoriasis triggered by microbiota in the skin?, British Journal of Dermatology, vol.169, issue.1, pp.47-52, 2013.
DOI : 10.1111/bjd.12322

L. Nibali, B. Henderson, S. Sadiq, and N. Donos, Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases, Journal of Oral Microbiology, vol.49, issue.1, 2014.
DOI : 10.3109/rhe1.1955.1.issue-1-4.15

C. Seillet, S. Laffont, F. Tremollieres, N. Rouquie, C. Ribot et al., The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor ?? signaling, Blood, vol.119, issue.2, pp.454-64, 2012.
DOI : 10.1182/blood-2011-08-371831
URL : https://hal.archives-ouvertes.fr/inserm-00726899

T. Kinnunen, N. Chamberlain, H. Morbach, J. Choi, S. Kim et al., Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells, Blood, vol.121, issue.9, pp.1595-603, 2013.
DOI : 10.1182/blood-2012-09-457465

N. Romberg, N. Chamberlain, D. Saadoun, M. Gentile, T. Kinnunen et al., CVID-associated TACI mutations affect autoreactive B cell selection and activation, Journal of Clinical Investigation, vol.123, issue.10, pp.4283-93, 2013.
DOI : 10.1172/JCI69854DS1

T. Means, E. Latz, F. Hayashi, M. Murali, D. Golenbock et al., Human lupus autoantibody???DNA complexes activate DCs through cooperation of CD32 and TLR9, Journal of Clinical Investigation, vol.115, issue.2, pp.407-424, 2005.
DOI : 10.1172/JCI23025DS1

A. Rodriguez-pla, P. Patel, H. Maecker, J. Rossello-urgell, N. Baldwin et al., IFN Priming Is Necessary but Not Sufficient To Turn on a Migratory Dendritic Cell Program in Lupus Monocytes, The Journal of Immunology, vol.192, issue.12, pp.5586-98, 2014.
DOI : 10.4049/jimmunol.1301319

R. Lande, J. Gregorio, V. Facchinetti, B. Chatterjee, Y. Wang et al., Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide, Nature, vol.7, issue.7162, pp.564-573, 2007.
DOI : 10.1038/nature06116

J. Taubenberger and D. Morens, The Pathology of Influenza Virus Infections, Annual Review of Pathology: Mechanisms of Disease, vol.3, issue.1, pp.499-522, 2008.
DOI : 10.1146/annurev.pathmechdis.3.121806.154316

C. Beadling and M. Slifka, How do viral infections predispose patients to bacterial infections?, Current Opinion in Infectious Diseases, vol.17, issue.3, pp.185-91, 2004.
DOI : 10.1097/00001432-200406000-00003

D. Morens, J. Taubenberger, and A. Fauci, Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness, The Journal of Infectious Diseases, vol.198, issue.7, pp.962-70, 2008.
DOI : 10.1086/591708

T. Kuiken and J. Taubenberger, Pathology of human influenza revisited, Vaccine, vol.26, pp.59-66, 2008.
DOI : 10.1016/j.vaccine.2008.07.025

D. Metzger and K. Sun, Immune Dysfunction and Bacterial Coinfections following Influenza, The Journal of Immunology, vol.191, issue.5, pp.2047-52, 2013.
DOI : 10.4049/jimmunol.1301152

G. Trinchieri, Type I interferon: friend or foe?, The Journal of Experimental Medicine, vol.5, issue.10, pp.2053-63, 2010.
DOI : 10.1002/hep.21970

L. Doughty, K. Nguyen, J. Durbin, and C. Biron, A Role for IFN-???? in Virus Infection-Induced Sensitization to Endotoxin, The Journal of Immunology, vol.166, issue.4, pp.2658-64, 2001.
DOI : 10.4049/jimmunol.166.4.2658

A. Shahangian, E. Chow, X. Tian, J. Kang, A. Ghaffari et al., Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice, Journal of Clinical Investigation, vol.119, issue.7, pp.1910-1930, 2009.
DOI : 10.1172/JCI35412DS1

S. Nakamura, K. Davis, and J. Weiser, Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice, Journal of Clinical Investigation, vol.121, issue.9, pp.3657-65, 2011.
DOI : 10.1172/JCI57762

L. Antonelli, G. Rothfuchs, A. Goncalves, R. Roffe, E. Cheever et al., Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population, Journal of Clinical Investigation, vol.120, issue.5, pp.1674-8210, 1172.
DOI : 10.1172/JCI40817DS1

K. Mayer-barber, B. Andrade, D. Barber, S. Hieny, C. Feng et al., Innate and Adaptive Interferons Suppress IL-1?? and IL-1?? Production by Distinct Pulmonary Myeloid Subsets during Mycobacterium tuberculosis Infection, Immunity, vol.35, issue.6, pp.1023-1057, 2011.
DOI : 10.1016/j.immuni.2011.12.002

K. Mayer-barber, B. Andrade, S. Oland, E. Amaral, D. Barber et al., Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk, Nature, vol.209, issue.7507, pp.99-10310, 1038.
DOI : 10.1038/nature13489

A. Reboldi, E. Dang, J. Mcdonald, G. Liang, D. Russell et al., 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon, Science, vol.345, issue.6197, pp.679-84, 2014.
DOI : 10.1126/science.1254790

M. Guilliams, F. Ginhoux, C. Jakubzick, S. Naik, N. Onai et al., Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny, Nature Reviews Immunology, vol.114, issue.8, pp.571-579, 2014.
DOI : 10.1038/nri3712

L. Daley-bauer, G. Wynn, and E. Mocarski, Cytomegalovirus Impairs Antiviral CD8+ T Cell Immunity by Recruiting Inflammatory Monocytes, Immunity, vol.37, issue.1, pp.122-155, 2012.
DOI : 10.1016/j.immuni.2012.04.014

J. Aldridge, . Jr, C. Moseley, D. Boltz, N. Negovetich et al., TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection, Proceedings of the National Academy of Sciences, vol.106, issue.13, pp.5306-5317, 2009.
DOI : 10.1073/pnas.0900655106

A. Kudva, E. Scheller, K. Robinson, C. Crowe, S. Choi et al., Influenza A Inhibits Th17-Mediated Host Defense against Bacterial Pneumonia in Mice, The Journal of Immunology, vol.186, issue.3, pp.1666-74, 2011.
DOI : 10.4049/jimmunol.1002194

K. Robinson, K. Mchugh, S. Mandalapu, M. Clay, B. Lee et al., Influenza A Virus Exacerbates Staphylococcus aureus Pneumonia in Mice by Attenuating Antimicrobial Peptide Production, Journal of Infectious Diseases, vol.209, issue.6, pp.865-75, 2014.
DOI : 10.1093/infdis/jit527

A. Jamieson, L. Pasman, S. Yu, P. Gamradt, R. Homer et al., Role of Tissue Protection in Lethal Respiratory Viral-Bacterial Coinfection, Science, vol.340, issue.6137, pp.1230-1234, 2013.
DOI : 10.1126/science.1233632

R. Medzhitov, D. Schneider, and M. Soares, Disease Tolerance as a Defense Strategy, Science, vol.335, issue.6071, pp.936-977, 2012.
DOI : 10.1126/science.1214935

L. Liu, S. Okada, X. Kong, A. Kreins, S. Cypowyj et al., mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis, The Journal of Experimental Medicine, vol.2, issue.8, pp.1635-1683, 2011.
DOI : 10.1073/pnas.0501063102

G. Guarda, M. Braun, F. Staehli, A. Tardivel, C. Mattmann et al., Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation, Immunity, vol.34, issue.2, pp.213-236, 2011.
DOI : 10.1016/j.immuni.2011.02.006

O. Majer, C. Bourgeois, F. Zwolanek, C. Lassnig, D. Kerjaschki et al., Type I Interferons Promote Fatal Immunopathology by Regulating Inflammatory Monocytes and Neutrophils during Candida Infections, PLoS Pathogens, vol.264, issue.7, 2012.
DOI : 10.1371/journal.ppat.1002811.s005

C. Biondo, A. Midiri, M. Gambuzza, E. Gerace, M. Falduto et al., IFN-??/?? Signaling Is Required for Polarization of Cytokine Responses toward a Protective Type 1 Pattern during Experimental Cryptococcosis, The Journal of Immunology, vol.181, issue.1, pp.566-73, 2008.
DOI : 10.4049/jimmunol.181.1.566

C. Del-fresno, D. Soulat, S. Roth, K. Blazek, I. Udalova et al., Interferon-?? Production via Dectin-1-Syk-IRF5 Signaling in Dendritic Cells Is Crucial for Immunity to C.??albicans, Immunity, vol.38, issue.6, pp.1176-86, 2013.
DOI : 10.1016/j.immuni.2013.05.010

A. Reder and X. Feng, Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology, Frontiers in Immunology, vol.4, 2013.
DOI : 10.3389/fimmu.2013.00281

R. Axtell and C. Raman, Janus-like effects of type I interferon in autoimmune diseases, Immunological Reviews, vol.253, issue.Pt 11, pp.23-35, 2012.
DOI : 10.1111/j.1600-065X.2012.01131.x

S. Blackburn, H. Shin, W. Haining, T. Zou, C. Workman et al., Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection, Nature Immunology, vol.81, issue.1, pp.29-37, 2009.
DOI : 10.1038/ni.1679

I. Osokine, L. Snell, C. Cunningham, D. Yamada, E. Wilson et al., Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection, Proceedings of the National Academy of Sciences, vol.111, issue.20, pp.7409-7423, 2014.
DOI : 10.1073/pnas.1401662111

Y. Wang, M. Swiecki, M. Cella, G. Alber, R. Schreiber et al., O032 Timing and magnitude of Type I interferon responses by distinct viral sensors impact CD8 T cell exhaustion and chronic infection, Cytokine, vol.59, issue.3, pp.631-673, 2012.
DOI : 10.1016/j.cyto.2012.06.066

M. Hyrcza, C. Kovacs, M. Loutfy, R. Halpenny, L. Heisler et al., Distinct Transcriptional Profiles in Ex Vivo CD4+ and CD8+ T Cells Are Established Early in Human Immunodeficiency Virus Type 1 Infection and Are Characterized by a Chronic Interferon Response as Well as Extensive Transcriptional Changes in CD8+ T Cells, Journal of Virology, vol.81, issue.7, pp.3477-861001552, 1128.
DOI : 10.1128/JVI.01552-06

A. Sedaghat, J. German, T. Teslovich, J. Cofrancesco, . Jr et al., Chronic CD4+ T-Cell Activation and Depletion in Human Immunodeficiency Virus Type 1 Infection: Type I Interferon-Mediated Disruption of T-Cell Dynamics, Journal of Virology, vol.82, issue.4, pp.1870-831002228, 1128.
DOI : 10.1128/JVI.02228-07

A. Smith, Q. Li, S. Wietgrefe, T. Schacker, C. Reilly et al., Host Genes Associated with HIV-1 Replication in Lymphatic Tissue, The Journal of Immunology, vol.185, issue.9, pp.5417-5441, 2010.
DOI : 10.4049/jimmunol.1002197

S. Bosinger, Q. Li, S. Gordon, N. Klatt, L. Duan et al., Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys, Journal of Clinical Investigation, vol.119, issue.12, pp.3556-7210, 1172.
DOI : 10.1172/JCI40115DS1

B. Jacquelin, V. Mayau, B. Targat, A. Liovat, D. Kunkel et al., Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response, Journal of Clinical Investigation, vol.119, issue.12, pp.3544-5510, 1172.
DOI : 10.1172/JCI40093DS1

L. Harris, T. B. Sodora, D. Paiardini, M. Klatt, N. Douek et al., Downregulation of Robust Acute Type I Interferon Responses Distinguishes Nonpathogenic Simian Immunodeficiency Virus (SIV) Infection of Natural Hosts from Pathogenic SIV Infection of Rhesus Macaques, Journal of Virology, vol.84, issue.15, pp.7886-911002612, 1128.
DOI : 10.1128/JVI.02612-09

M. Rotger, J. Dalmau, A. Rauch, P. Mclaren, S. Bosinger et al., Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque, Journal of Clinical Investigation, vol.121, issue.6, pp.2391-40010, 1172.
DOI : 10.1172/JCI45235DS1

A. Hardy, D. Graham, G. Shearer, and J. Herbeuval, HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-??, Proceedings of the National Academy of Sciences, vol.104, issue.44, pp.17453-17461, 2007.
DOI : 10.1073/pnas.0707244104
URL : https://hal.archives-ouvertes.fr/hal-00177945

G. Stary, I. Klein, S. Kohlhofer, F. Koszik, T. Scherzer et al., Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients, Blood, vol.114, issue.18, pp.3854-63, 2009.
DOI : 10.1182/blood-2009-04-217927

A. Meier, J. Chang, E. Chan, R. Pollard, H. Sidhu et al., Sex differences in the Toll-like receptor???mediated response of plasmacytoid dendritic cells to HIV-1, Nature Medicine, vol.265, issue.8, pp.955-964, 2004.
DOI : 10.1038/nm.2004

Q. Li, J. Estes, P. Schlievert, L. Duan, A. Brosnahan et al., Glycerol monolaurate prevents mucosal SIV transmission, Nature, vol.189, issue.7241, pp.1034-1042, 2009.
DOI : 10.1038/nature07831

N. Sandler, S. Bosinger, J. Estes, R. Zhu, G. Tharp et al., Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression, Nature, vol.37, issue.7511, pp.601-606, 2014.
DOI : 10.1182/blood-2012-06-437608

G. Li, M. Cheng, J. Nunoya, L. Cheng, H. Guo et al., Plasmacytoid Dendritic Cells Suppress HIV-1 Replication but Contribute to HIV-1 Induced Immunopathogenesis in Humanized Mice, PLoS Pathogens, vol.140, issue.12, 2014.
DOI : 10.1371/journal.ppat.1004291.s005

A. Wendt, X. Adhoute, P. Castellani, V. Oules, C. Ansaldi et al., Chronic hepatitis C: future treatment, Clin Pharmacol, vol.6, pp.1-17, 2014.

J. Baugh, J. Garcia-rivera, and P. Gallay, Host-targeting agents in the treatment of hepatitis C: A beginning and an end?, Antiviral Research, vol.100, issue.2, pp.555-61, 2013.
DOI : 10.1016/j.antiviral.2013.09.020

S. Pestka, The Interferons: 50 Years after Their Discovery, There Is Much More to Learn, Journal of Biological Chemistry, vol.282, issue.28, pp.20047-51, 2007.
DOI : 10.1074/jbc.R700004200

S. Park and B. Rehermann, Immune Responses to HCV and Other Hepatitis Viruses, Immunity, vol.40, issue.1, pp.13-24, 2014.
DOI : 10.1016/j.immuni.2013.12.010

T. Sheahan, N. Imanaka, S. Marukian, M. Dorner, P. Liu et al., Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness, Cell Host & Microbe, vol.15, issue.2, pp.190-202, 2014.
DOI : 10.1016/j.chom.2014.01.007

T. Miyagi, T. Takehara, K. Nishio, S. Shimizu, K. Kohga et al., Altered interferon-??-signaling in natural killer cells from patients with chronic hepatitis C virus infection, Journal of Hepatology, vol.53, issue.3, pp.424-454, 2010.
DOI : 10.1016/j.jhep.2010.03.018

G. Ahlenstiel, R. Titerence, C. Koh, B. Edlich, J. Feld et al., Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa???Dependent Manner, Gastroenterology, vol.138, issue.1, pp.1-2, 2010.
DOI : 10.1053/j.gastro.2009.08.066

B. Bengsch, B. Seigel, M. Ruhl, J. Timm, M. Kuntz et al., Coexpression of PD-1, 2B4

D. Hartigan-o-'connor, D. Lin, J. Ryan, V. Shvachko, M. Cozen et al., Monocyte Activation by Interferon ?? Is Associated With Failure to Achieve a Sustained Virologic Response After Treatment for Hepatitis C Virus Infection, Journal of Infectious Diseases, vol.209, issue.10, pp.1602-1614, 2014.
DOI : 10.1093/infdis/jit801

D. Thomas, C. Thio, M. Martin, Y. Qi, D. Ge et al., Genetic variation in IL28B and spontaneous clearance of hepatitis C virus, Nature, vol.119, issue.7265, pp.798-80110, 1038.
DOI : 10.1038/nature08463

D. Ge, J. Fellay, A. Thompson, J. Simon, K. Shianna et al., Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance, Nature, vol.18, issue.7262, pp.399-401, 2009.
DOI : 10.1038/nature08309

L. Prokunina-olsson, B. Muchmore, W. Tang, R. Pfeiffer, H. Park et al., A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus, Nature Genetics, vol.29, issue.2, pp.164-71, 2013.
DOI : 10.1073/pnas.96.19.10800

A. Mcfarland, S. Horner, A. Jarret, R. Joslyn, E. Bindewald et al., The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus???induced microRNAs, Nature Immunology, vol.612, issue.1, pp.72-81, 2014.
DOI : 10.1128/JVI.77.4.2578-2586.2003

A. Kohli, X. Zhang, Y. J. Russell, R. Donnelly, R. Sheikh et al., Distinct and overlapping genomic profiles and antiviral effects of Interferon-?? and -?? on HCV-infected and noninfected hepatoma cells, Journal of Viral Hepatitis, vol.54, issue.6, pp.843-53, 2012.
DOI : 10.1111/j.1365-2893.2012.01610.x

S. Nakagawa, Y. Hirata, T. Kameyama, Y. Tokunaga, Y. Nishito et al., Targeted induction of interferon-lambda in humanized chimeric mouse liver abrogates hepatotropic virus infection, PLoS One, vol.8, issue.3, 2013.

F. Duong, G. Trincucci, T. Boldanova, D. Calabrese, B. Campana et al., genotype and with nonresponsiveness to IFN-?? therapies, The Journal of Experimental Medicine, vol.261, issue.5, pp.857-68, 2014.
DOI : 10.3892/ijmm_00000408

G. Stark, I. Kerr, B. Williams, R. Silverman, and R. Schreiber, HOW CELLS RESPOND TO INTERFERONS, Annual Review of Biochemistry, vol.67, issue.1, pp.227-64, 1998.
DOI : 10.1146/annurev.biochem.67.1.227

J. Darnell, . Jr, I. Kerr, and G. Stark, Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins, Science, vol.264, issue.5164, pp.1415-1436, 1994.
DOI : 10.1126/science.8197455

L. Ivashkiv and L. Donlin, Regulation of type I interferon responses, Nature Reviews Immunology, vol.7, issue.1, pp.36-49, 2014.
DOI : 10.1038/nri3581

K. Fink and N. Grandvaux, STAT2 and IRF9, JAK-STAT, vol.163, issue.4, 2013.
DOI : 10.1016/j.tibtech.2013.04.004

S. Bendall, E. Simonds, P. Qiu, A. Amir-el, P. Krutzik et al., Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum, Science, vol.332, issue.6030, pp.687-96, 2011.
DOI : 10.1126/science.1198704

B. Bodenmiller, E. Zunder, R. Finck, T. Chen, E. Savig et al., Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators, Nature Biotechnology, vol.9, issue.9, pp.858-67, 2012.
DOI : 10.1126/science.1176615

A. Van-boxel-dezaire, J. Zula, Y. Xu, R. Ransohoff, J. Jacobberger et al., Major Differences in the Responses of Primary Human Leukocyte Subsets to IFN-??, The Journal of Immunology, vol.185, issue.10, pp.5888-99, 2010.
DOI : 10.4049/jimmunol.0902314

K. Nguyen, W. Watford, R. Salomon, S. Hofmann, G. Pien et al., Critical Role for STAT4 Activation by Type 1 Interferons in the Interferon-gamma Response to Viral Infection, Science, vol.297, issue.5589, pp.2063-2069, 2002.
DOI : 10.1126/science.1074900

J. Gonzalez-navajas, J. Lee, M. David, and E. Raz, Immunomodulatory functions of type I interferons, Nature Reviews Immunology, vol.170, issue.2, pp.125-160, 2012.
DOI : 10.1038/nri3133

T. Miyagi, M. Gil, X. Wang, J. Louten, W. Chu et al., High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells, The Journal of Experimental Medicine, vol.69, issue.10, pp.2383-96, 2007.
DOI : 10.1128/JVI.76.9.4520-4525.2002

E. Mack, L. Kallal, D. Demers, and C. Biron, Type 1 Interferon Induction of Natural Killer Cell Gamma Interferon Production for Defense during Lymphocytic Choriomeningitis Virus Infection, mBio, vol.2, issue.4, pp.169-111000169, 1128.
DOI : 10.1128/mBio.00169-11

L. Kallal and C. Biron, Changing partners at the dance, JAK-STAT, vol.161, issue.1, 2013.
DOI : 10.1016/j.immuni.2011.09.016

R. Longman, D. Braun, S. Pellegrini, C. Rice, R. Darnell et al., Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-??/?? on antigen cross-presentation, Blood, vol.109, issue.3, pp.1113-1135, 2007.
DOI : 10.1182/blood-2006-05-023465
URL : https://hal.archives-ouvertes.fr/pasteur-00161659

L. Platanias, Mechanisms of type-I- and type-II-interferon-mediated signalling, Nature Reviews Immunology, vol.132, issue.5, pp.375-86, 2005.
DOI : 10.1001/jama.290.24.3222

K. Honda, A. Takaoka, and T. Taniguchi, Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors, Immunity, vol.25, issue.3, pp.349-60, 2006.
DOI : 10.1016/j.immuni.2006.08.009

A. Van-boxel-dezaire, M. Rani, and G. Stark, Complex Modulation of Cell Type-Specific Signaling in Response to Type I Interferons, Immunity, vol.25, issue.3, pp.361-72, 2006.
DOI : 10.1016/j.immuni.2006.08.014

D. Kalvakolanu, Alternate interferon signaling pathways, Pharmacology & Therapeutics, vol.100, issue.1, pp.1-29, 2003.
DOI : 10.1016/S0163-7258(03)00070-6

J. Sanceau, J. Hiscott, O. Delattre, and J. Wietzerbin, IFN-?? induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7, Oncogene, vol.19, issue.30, pp.3372-83, 2000.
DOI : 10.1038/sj.onc.1203670

V. Francois-newton, M. De-freitas-almeida, G. Payelle-brogard, B. Monneron, D. Pichard-garcia et al., USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon alpha response, PLoS One, vol.6, issue.7, 2011.

L. Coelho, M. De-freitas-almeida, G. Mennechet, F. Blangy, A. Uze et al., Interferon-?? and -?? differentially regulate osteoclastogenesis: Role of differential induction of chemokine CXCL11 expression, Proceedings of the National Academy of Sciences, vol.102, issue.33, pp.11917-11939, 2005.
DOI : 10.1073/pnas.0502188102

G. Garcin, Y. Bordat, P. Chuchana, D. Monneron, H. Law et al., Differential Activity of Type I Interferon Subtypes for Dendritic Cell Differentiation, PLoS ONE, vol.2, issue.3, 2013.
DOI : 10.1371/journal.pone.0058465.t002

J. Manry, G. Laval, E. Patin, S. Fornarino, Y. Itan et al., Evolutionary genetic dissection of human interferons, The Journal of Experimental Medicine, vol.30, issue.13, pp.2747-59, 2011.
DOI : 10.1111/j.1600-065X.2008.00698.x

G. Uze, G. Schreiber, J. Piehler, and S. Pellegrini, The receptor of the type I interferon family, Curr Top Microbiol Immunol, vol.316, pp.71-95, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00202867

C. Berry, P. Hertzog, and N. Mangan, Interferons as biomarkers and effectors: lessons learned from animal models, Biomarkers in Medicine, vol.6, issue.2, pp.159-76, 2012.
DOI : 10.2217/bmm.12.10

J. Mattner, A. Wandersee-steinhauser, A. Pahl, M. Rollinghoff, G. Majeau et al., Protection against progressive leishmaniasis by IFN-beta

D. Levin, W. Schneider, H. Hoffmann, G. Yarden, A. Busetto et al., Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist, Science Signaling, vol.7, issue.327, 2014.
DOI : 10.1126/scisignal.2004998

I. Moraga, D. Harari, G. Schreiber, G. Uze, and S. Pellegrini, Receptor Density Is Key to the Alpha2/Beta Interferon Differential Activities, Molecular and Cellular Biology, vol.29, issue.17, pp.4778-87, 2009.
DOI : 10.1128/MCB.01808-08
URL : https://hal.archives-ouvertes.fr/hal-00459061

J. Piehler, C. Thomas, K. Garcia, and G. Schreiber, Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation, Immunological Reviews, vol.6, issue.1, pp.317-351, 2012.
DOI : 10.1111/imr.12001

K. Mogensen, M. Lewerenz, J. Reboul, G. Lutfalla, and G. Uze, The Type I Interferon Receptor: Structure, Function, and Evolution of a Family Business, Journal of Interferon & Cytokine Research, vol.19, issue.10, pp.1069-98, 1999.
DOI : 10.1089/107999099313019

E. Jaks, M. Gavutis, G. Uze, J. Martal, and J. Piehler, Differential Receptor Subunit Affinities of Type I Interferons Govern Differential Signal Activation, Journal of Molecular Biology, vol.366, issue.2, pp.525-564, 2007.
DOI : 10.1016/j.jmb.2006.11.053
URL : https://hal.archives-ouvertes.fr/hal-00167456

C. Thomas, I. Moraga, D. Levin, P. Krutzik, Y. Podoplelova et al., Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons, Cell, vol.146, issue.4, pp.621-653, 2011.
DOI : 10.1016/j.cell.2011.06.048

M. Prinz, H. Schmidt, A. Mildner, K. Knobeloch, U. Hanisch et al., Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System, Immunity, vol.28, issue.5, pp.675-86, 2008.
DOI : 10.1016/j.immuni.2008.03.011

J. Crouse, G. Bedenikovic, M. Wiesel, M. Ibberson, I. Xenarios et al., Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1, Immunity, vol.40, issue.6, pp.961-73, 2014.
DOI : 10.1016/j.immuni.2014.05.003

S. Kunz, K. Oberle, A. Sander, C. Bogdan, and U. Schleicher, Lymphadenopathy in a Novel Mouse Model of Bartonella-Induced Cat Scratch Disease Results from Lymphocyte Immigration and Proliferation and Is Regulated by Interferon-??/??, The American Journal of Pathology, vol.172, issue.4, pp.1005-18070591, 2008.
DOI : 10.2353/ajpath.2008.070591

A. Dann, H. Poeck, A. Croxford, S. Gaupp, K. Kierdorf et al., Cytosolic RIG-I???like helicases act as negative regulators of sterile inflammation in the CNS, Nature Neuroscience, vol.7, issue.1, pp.98-106, 2012.
DOI : 10.1038/nn.2964

T. Schwandt, B. Schumak, G. Gielen, F. Jungerkes, P. Schmidbauer et al., Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis, The EMBO Journal, vol.4, issue.1, pp.201-214, 2012.
DOI : 10.1038/emboj.2011.380

P. Goossens, M. Gijbels, A. Zernecke, W. Eijgelaar, M. Vergouwe et al., Myeloid Type I Interferon Signaling Promotes Atherosclerosis by Stimulating Macrophage Recruitment to Lesions, Cell Metabolism, vol.12, issue.2, pp.142-53, 2010.
DOI : 10.1016/j.cmet.2010.06.008

K. Takeda, T. Kaisho, N. Yoshida, J. Takeda, T. Kishimoto et al., Correction: Stat3 Activation Is Responsible for IL-6???Dependent T Cell Proliferation through Preventing Apoptosis: Generation and Characterization of T Cell???Specific Stat3-Deficient Mice, The Journal of Immunology, vol.194, issue.7, pp.1614652-60, 1998.
DOI : 10.4049/jimmunol.1500168

B. Wallner, N. Leitner, R. Vielnascher, E. Kernbauer, T. Kolbe et al., Generation of mice with a conditional Stat1 null allele, Transgenic Research, vol.226, issue.1, pp.217-241, 2012.
DOI : 10.1007/s11248-011-9519-5

E. Kernbauer, V. Maier, D. Stoiber, B. Strobl, C. Schneckenleithner et al., Conditional Stat1 Ablation Reveals the Importance of Interferon Signaling for Immunity to Listeria monocytogenes Infection, PLoS Pathogens, vol.108, issue.6, 2012.
DOI : 10.1371/journal.ppat.1002763.s008

P. Klover, W. Muller, G. Robinson, R. Pfeiffer, D. Yamaji et al., Loss of STAT1 from Mouse Mammary Epithelium Results in an Increased Neu-Induced Tumor Burden, Neoplasia, vol.12, issue.11, pp.899-905, 2010.
DOI : 10.1593/neo.10716

Y. Cui, G. Riedlinger, K. Miyoshi, W. Tang, C. Li et al., Inactivation of Stat5 in Mouse Mammary Epithelium during Pregnancy Reveals Distinct Functions in Cell Proliferation, Survival, and Differentiation, Molecular and Cellular Biology, vol.24, issue.18, pp.8037-8084, 2004.
DOI : 10.1128/MCB.24.18.8037-8047.2004

M. Buehler, B. Tse, A. Leboucq, F. Jacob, R. Caduff et al., Meta-analysis of microarray data identifies GAS6 expression as an independent predictor of poor survival in ovarian cancer, Biomed Res Int, 2013.

M. Hutterer, P. Knyazev, A. Abate, M. Reschke, H. Maier et al., Axl and Growth Arrest Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme, Clinical Cancer Research, vol.14, issue.1, pp.130-138, 2008.
DOI : 10.1158/1078-0432.CCR-07-0862

S. Whitman, J. Kohlschmidt, K. Maharry, S. Volinia, K. Mrozek et al., GAS6 expression identifies high-risk adult AML patients: potential implications for therapy, Leukemia, vol.21, issue.6, pp.1252-1260, 2014.
DOI : 10.1182/blood-2011-10-383406

U. Scarlett, M. Rutkowski, A. Rauwerdink, J. Fields, X. Escovar-fadul et al., Ovarian cancer progression is controlled by phenotypic changes in dendritic cells, The Journal of Experimental Medicine, vol.63, issue.3, pp.495-506, 2012.
DOI : 10.1056/NEJMoa020177

M. Essers, S. Offner, W. Blanco-bose, Z. Waibler, U. Kalinke et al., IFN?? activates dormant haematopoietic stem cells in vivo, Nature, vol.6, issue.7240, pp.904-912, 2009.
DOI : 10.1038/nature07815

T. Nagai, O. Devergne, T. Mueller, D. Perkins, J. Van-seventer et al., Timing of IFN-?? Exposure during Human Dendritic Cell Maturation and Naive Th Cell Stimulation Has Contrasting Effects on Th1 Subset Generation: A Role for IFN-??-Mediated Regulation of IL-12 Family Cytokines and IL-18 in Naive Th Cell Differentiation, The Journal of Immunology, vol.171, issue.10, pp.5233-5276, 2003.
DOI : 10.4049/jimmunol.171.10.5233

M. Touzot, M. Grandclaudon, A. Cappuccio, T. Satoh, C. Martinez-cingolani et al., Combinatorial flexibility of cytokine function during human T helper cell differentiation, Nature Communications, vol.3, 2014.
DOI : 10.1038/ncomms4987

M. Gil, M. Ploquin, W. Watford, S. Lee, K. Kim et al., Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function, Blood, vol.120, issue.18, pp.3718-3746, 2012.
DOI : 10.1182/blood-2012-05-428672

E. Borden, G. Sen, G. Uze, R. Silverman, R. Ransohoff et al., Interferons at age 50: past, current and future impact on biomedicine, Nature Reviews Drug Discovery, vol.56, issue.12, pp.975-9010, 1038.
DOI : 10.1038/nrd2422
URL : https://hal.archives-ouvertes.fr/hal-00203077

D. Jaitin, L. Roisman, E. Jaks, M. Gavutis, J. Piehler et al., Inquiring into the Differential Action of Interferons (IFNs): an IFN-??2 Mutant with Enhanced Affinity to IFNAR1 Is Functionally Similar to IFN-??, Molecular and Cellular Biology, vol.26, issue.5
DOI : 10.1128/MCB.26.5.1888-1897.2006

E. Kalie, D. Jaitin, R. Abramovich, and G. Schreiber, An Interferon ??2 Mutant Optimized by Phage Display for IFNAR1 Binding Confers Specifically Enhanced Antitumor Activities, Journal of Biological Chemistry, vol.282, issue.15, pp.11602-11613, 2007.
DOI : 10.1074/jbc.M610115200

E. Kalie, D. Jaitin, Y. Podoplelova, J. Piehler, and G. Schreiber, The Stability of the Ternary Interferon-Receptor Complex Rather than the Affinity to the Individual Subunits Dictates Differential Biological Activities, Journal of Biological Chemistry, vol.283, issue.47, pp.32925-32961, 2008.
DOI : 10.1074/jbc.M806019200

A. Cozzio, W. Kempf, R. Schmid-meyer, M. Gilliet, S. Michaelis et al., Intra-lesional low-dose interferon ??2a therapy for primary cutaneous marginal zone B-cell lymphoma, Leukemia & Lymphoma, vol.2, issue.5, pp.865-910, 1080.
DOI : 10.1002/1097-0142(20001015)89:8<1835::AID-CNCR26>3.0.CO;2-H

J. Dubrot, A. Palazon, C. Alfaro, A. Azpilikueta, M. Ochoa et al., Intratumoral injection of interferon-?? and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy, International Journal of Cancer, vol.15, issue.1, pp.105-123, 2011.
DOI : 10.1002/ijc.25333

L. Armstrong, J. Davydova, E. Brown, J. Han, M. Yamamoto et al., Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy, Surgery, vol.152, issue.1, pp.114-136, 2012.
DOI : 10.1016/j.surg.2012.02.017

B. Burnette, H. Liang, Y. Lee, L. Chlewicki, N. Khodarev et al., The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity, Cancer Research, vol.71, issue.7, pp.2488-96, 2011.
DOI : 10.1158/0008-5472.CAN-10-2820

D. Sterman, A. Haas, E. Moon, A. Recio, D. Schwed et al., A Trial of Intrapleural Adenoviral-mediated Interferon-??2b Gene Transfer for Malignant Pleural Mesothelioma, American Journal of Respiratory and Critical Care Medicine, vol.184, issue.12, pp.1395-1404, 2011.
DOI : 10.1164/rccm.201103-0554CR

D. Palma, M. Mazzieri, R. Politi, L. Pucci, F. Zonari et al., Tumor-Targeted Interferon-?? Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis, Cancer Cell, vol.14, issue.4, pp.299-311, 2008.
DOI : 10.1016/j.ccr.2008.09.004

G. Adams, S. Vessillier, H. Dreja, and Y. Chernajovsky, Targeting cytokines to inflammation sites, Nature Biotechnology, vol.21, issue.11, pp.1314-1334, 2003.
DOI : 10.1038/nbt888

E. Coulstock, J. Sosabowski, M. Ovecka, R. Prince, L. Goodall et al., Livertargeting of interferon-alpha with tissue-specific domain antibodies, PLoS One, vol.8, issue.2, 2013.

K. Frey, A. Zivanovic, K. Schwager, and D. Neri, Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation, Integrative Biology, vol.11, issue.6, pp.468-78, 2011.
DOI : 10.1039/c0ib00099j

T. Huang, K. Chintalacharuvu, and S. Morrison, Targeting IFN-?? to B Cell Lymphoma by a Tumor-Specific Antibody Elicits Potent Antitumor Activities, The Journal of Immunology, vol.179, issue.10, pp.6881-6889, 2007.
DOI : 10.4049/jimmunol.179.10.6881

X. Yang, X. Zhang, M. Fu, R. Weichselbaum, T. Gajewski et al., Targeting the Tumor Microenvironment with Interferon-?? Bridges Innate and Adaptive Immune Responses, Cancer Cell, vol.25, issue.1, pp.37-48, 2014.
DOI : 10.1016/j.ccr.2013.12.004

C. Xuan, K. Steward, J. Timmerman, and S. Morrison, Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma, Blood, vol.115, issue.14, pp.2864-71, 2009.
DOI : 10.1182/blood-2009-10-250555

C. Ji, K. Sastry, G. Tiefenthaler, J. Cano, T. Tang et al., Targeted delivery of interferon-?? to hepatitis B virus-infected cells using T-cell receptor-like antibodies, Hepatology, vol.115, issue.Suppl 2, pp.2027-2065, 2012.
DOI : 10.1002/hep.25875

M. Slutzki, D. Jaitin, T. Yehezkel, and G. Schreiber, Variations in the Unstructured C-terminal Tail of Interferons Contribute to Differential Receptor Binding and Biological Activity, Journal of Molecular Biology, vol.360, issue.5, 2006.
DOI : 10.1016/j.jmb.2006.05.069

J. Mcbride, J. Jiang, A. Abbas, A. Morimoto, J. Li et al., Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo-controlled, double-blind, dose-escalation study, Arthritis & Rheumatism, vol.10, issue.Suppl 1, pp.3666-76, 2012.
DOI : 10.1002/art.34632